Amsterdam Gastroenterology Endocrinology Metabolism
-
Pembrolizumab with chemoradiotherapy followed by pembrolizumab for stage III–IVa cervical cancer: is the ENGOT-cx11/GOG-3047/KEYNOTE-A18 trial practice changing?
Penninx, B. M. F., Samson, M. J. & Schnog, J.-J. B., 15 Feb 2025, In: Cancer. 131, 4, e35749.Research output: Contribution to journal › Comment/Letter to the editor* › Academic
- All publications